Skip to main content

Site notifications

Sanofi-Aventis Pty Ltd

Regulatory activities for this sponsor.

Sponsor content

3 result(s) found, displaying 1 to 3
  • Libtayo (cemiplimab) is provisionally approved to treat cutaneous squamous cell carcinoma in adults
  • Australian prescription medicine decision summary

Help us improve the Therapeutic Goods Administration site